tilmicosin premix, veterinary drugs, animal drugs,18 years GMP supply

We are manufacturer of tilmicosin premix and other pharmaceutical intermediates,contact us for more details. Specifications

Tilmicosin premix assay :95%min standard :usp25 packing :25kg/drum

Tilmicosin premix

assay  :95%minstandard :usp25packing :25kg/drum

Indications

Tilmicosin has in vitro activity against gram-positive organisms and mycoplasma and is active against certain gram-negative organisms, such as Histophilus somni (Haemophilus somnus), Mannheimia (Pasteurella) haemolytica, and Pasteurella multocida. However, M. haemolytica is more sensitive than P. multocida to tilmicosin. Other gram-negative organisms tested, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella, and Serratia species, are very resistant to tilmicosin. Some strains of Actinomyces also are extremely resistant to tilmicosin.

Pigs: Tilmicosin for medicated feed is indicated in the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida.

Usual dose

 Pneumonia, bacterialPigs: Oral, 181 to 383 grams per ton of feed, fed as the only ration for twenty-one days, beginning approximately seven days before an anticipated disease outbreak,

if possible.

Withdrawal times

US and Canada: Meat7 days.

China:Pigs-14 days.

Packaging

200 grams (base) per kg.

Storage

Store below 40 °C (104 °F), preferably between 4 and 20 °C (59 and 86 °F).

tilmicosin premix, veterinary drugs, animal drugs,18 years GMP supply